CClinicalTrials.gg
Status unknownNCT04874389Updated May 6, 2021

Multidimensional Classification of Mild Traumatic Brain Injury (mTBI)

An observational study in Mild Traumatic Brain Injury, sponsored by Clea Tucker. Status unknown at 1 site in United States. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2021-05-06.

Sponsored by Clea Tucker · Observational

The sponsor has not verified this record recently (last verified May 2021), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
50
Ages
18 Years to 50 Years
Sex
All
01

Study summary

This study aims to explore possible solutions needed for valid and reliable multidimensional objective assessment tools to use in screening performers for concussions, as well as, for use postinjury assessment and management of the mild traumatic brain injury, regardless of time since injury occurrence. These mobile tools would also enable clinicians to test the effectiveness of the interventions used post-concussion, prior to fully releasing the performer back into full performance/active status.

Read the detailed description

Participants will have study benefits and risks explained to them and after consent has been obtained each participant will be assigned an Identification number and attend their assigned testing day.

Testing day will consist of completing a seven page clinician-created medical-health questionnaire to determine that they are free of cardiovascular, metabolic, psychiatric or neurologic disease, do not have cognitive or substance-abuse problems or are taking any medications that may impair cognition, balance or functional mobility such as gait.

Participants will also complete the Brain Injury Screening Questionnaire (BISQ, Mount Sinai School of Medicine, New York, NY) to additionally screen for lifetime history of traumatic brain injury (TBI) and reduce consequences of undiagnosed mTBI.

Tests will then be conducted in three parts. First, to evaluate neuromotor and neurocognitive abilities, participants will complete a modified balance error test and a modified version of the dynamic gait index without and with additional cognitive tasks. These tests will be performed while wearing external sensors recording kinematic data and a (wearable) functional near-infrared spectroscopy cap system (NIRSport1) unit monitoring brain tissue oxygenation and perfusion.

Second test that the above multimodal test will be compared to is the sport concussion assessment tool (SCAT 5).

The third test conducted and used to compare the multimodal approach to will be the Immediate post-concussion and cognitive testing (ImPACT).

Participants will be allotted a 15-minute break period between each test.

02

Conditions studied

  • Mild Traumatic Brain Injury

Keywords

  • brain oxygenation
  • functional multimodal assessment
  • dual tasking
  • traumatic brain injury
  • balance
  • gait
  • cognition
03

In context

Brain Injuries

2,113 studies on the registry are indexed under Brain Injuries; 385 are open to participants now.

This study's planned enrollment of 50 is below the median of 100 across 690 observational studies indexed under Brain Injuries.

Browse Brain Injuries studies →

Lead sponsor

This is the only study on the registry with Clea Tucker as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

50 male and female athletes and performers will be invited to participate.

Inclusion criteria

  • Recreationally healthy and active or considered an athletic performer, males and females, to regularly engage in >150 min/week of physical activity.
  • Participants considered an athletic performer if they have history of participating in athletics at the university, amateur, elite or professional level, or are a military veteran.
  • Healthy participants defined as not currently injured, or recovering from an injury within the past 12 months, or undergone surgery within the last 12 months, or with any known history of moderate to severe traumatic brain injury resulting in impaired judgement or inability to make sound decisions within the last 12 months.
  • Post concussion participants are eligible if their last concussive event occurred within a month and up to 5 years of the date of data collection.

Exclusion criteria

Exclusion Criteria:

  • If younger than 18 or >50 years of age.
  • Current cardiovascular, metabolic, psychiatric, or neurologic disease or cognitive or substance-abuse problems or taking medications that may impair cognition, balance, or functional mobility such as gait.
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
50 participants (estimated)
Patient registry
No

Groups and cohorts

  • Recreationally active males and females

    Subjects to be considered recreationally must regularly engage in \>150 min/wk of physical activity (e.g., resistance training, sport or activity specific exercise, group exercise, or aerobic exercise). Healthy participants, defined as not currently injured, or recovering from an injury within the past 12 months, or undergone surgery within the last 12 months, or with any known history of moderate to severe traumatic brain injury resulting in impaired judgment or inability to make sound decisions or mild traumatic brain injury (mTBI, also commonly named "concussion") within the last 12 months.

    Diagnostic Test: Multimodal Assessment

  • Athletes or performing artists with reported history of concussion

    Participants will be considered if they are recreationally active or considered an athletic performer (i.e.,history of participation in athletics at the university, amateur, elite or professional levels, or a military veteran), or a performing artist (i.e., stunt actors, circus artists, dancers or acrobats) with reported history of concussion incident(s), with most recent incident occurring \>1 month and less than five years from the study testing dates.

    Diagnostic Test: Multimodal Assessment

Interventions

  • Diagnostic testMultimodal Assessment

    Participants will complete BISQ/health questionnaire and proceed to each testing station with 15 minute rest breaks in between randomly ordered assigned stations.

    Also known as: Immediate Post-Concussion and Cognitive Testing (ImPACT), Sport Concussion Assessment Tool (SCAT 5), Brain Injury Screening Questionnaire (BISQ), Combined Functional near-infrared spectroscopy (fNIRS) with external kinematic sensors +modified Balance Error Scoring System (mBESS) and modified Dynamic Gait Index (mDGI) _ cognitive tasks

06

What researchers measure

Primary outcomes

  1. Proof of concept for the use of multimodal objective measures for mTBI assessment & treatment guide

    Demonstrate functional objective measures can be used regardless of time since injury to provide improved clinical diagnosis, determinant of injury, remanence of injury events still occurring

    Time frame: 3-6 months for data acquisition and data analysis

Secondary outcomes

  1. Advanced portability of functional objective testing in concussion

    Exploration of combined wearable tools to provide functional objective data that better reflect brain activity and possible impairments post concussion throughout brains recovery

    Time frame: 3-6 months for data acquisition and data analysis

07

Study locations

1 of 1 sites recruiting
  • California State University, Los Angeles
    Los Angeles, California 90032, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 6, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04874389
Lead sponsor
Clea Tucker
Responsible party
Clea Tucker (Assistant Professor; Doctor of Physical Therapy, California State University, Los Angeles) — Sponsor-investigator
First posted
May 5, 2021
Start date
May 2021 (estimated)
Primary completion
Jul 2021 (estimated)
Completion
Aug 2021 (estimated)
Last update
May 6, 2021

Study contacts

Clea P Tucker, DPT
Contact
ctucker@calstatela.edu
3233434641

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion